Verana Health’s newly launched Qdata Cataract offers a comprehensive dataset to improve outcomes, reduce complications and ...

In the weeks to come, the European Commission will issue a decision on the first severe thyroid eye disease treatment.

Dr. Subrata Batabyal earns the 2025 Carl Camras Award for innovative optogenetic therapies, advancing vision restoration for ...

Pykus Therapeutics reveals promising results for PYK-2101, a retinal sealant that enhances recovery and improves patient ...

The Virtual Eye Simulation Analyzer is an AI-driven digital twin of the human eye designed to model aging and personalize ...

Discover groundbreaking research and presentations from leading companies at the ARVO 2025 Annual Meeting, advancing ...

The clearance expands its existing label from patients aged 4 to 7 years to patients aged 4 to under 13 years.

D-150 is a potential backbone therapy that is designed to provide multi-year sustained delivery of anti-VEGF (aflibercept and ...

Urcosimod has received FDA fast track designation for neuropathic corneal pain, enabling expedited regulatory processes and ...

Scientists enhance eye imaging with AI, achieving high-resolution views of retinal cells, potentially revolutionizing disease ...

Explore the challenges and strategies of private practice management, focusing on financial sustainability and patient care ...

Shehzad Batliwala, DO, known to his patients as Dr. Shehz, appeared on the ASCRS Foundation Symposium, where he discussed ...